'Like Insider Trading' | GenomeWeb

One part of reading grant proposals Proflife Substance particularly enjoys is that it makes him think about his own work differently. But, he says, "herein lies a dilemma with all reviewing — determining where the line is between stimulating independent thought and leaning on someone else's ideas."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.